undecylenic acid 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 3446 | 112-38-9 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
a fatty acid with a terminal double bond
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | D01AE04 | DERMATOLOGICALS ANTIFUNGALS FOR DERMATOLOGICAL USE ANTIFUNGALS FOR TOPICAL USE Other antifungals for topical use |
| ATC | D01AE54 | DERMATOLOGICALS ANTIFUNGALS FOR DERMATOLOGICAL USE ANTIFUNGALS FOR TOPICAL USE Other antifungals for topical use |
| CHEBI has role | CHEBI:76924 | plant metabolites |
| CHEBI has role | CHEBI:86327 | pharmaceutical fungicide |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Tinea pedis | indication | 6020002 | DOID:12403 |
| Tinea corporis | indication | 84849002 | |
| Tinea Infections | indication |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 4.76 | acidic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| 4019122 | VUID |
| N0000178998 | NUI |
| D02159 | KEGG_DRUG |
| 4019122 | VANDF |
| C0041660 | UMLSCUI |
| CHEBI:39448 | CHEBI |
| CHEMBL1276010 | ChEMBL_ID |
| DB11117 | DRUGBANK_ID |
| 5634 | PUBCHEM_CID |
| C538763 | MESH_SUPPLEMENTAL_RECORD_UI |
| K3D86KJ24N | UNII |
| 10989 | RXNORM |
| 5342 | MMSL |
| 5654 | MMSL |
| 002892 | NDDF |
| 111145002 | SNOMEDCT_US |
| 386990002 | SNOMEDCT_US |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| HC Max Hongo CuraMS | HUMAN OTC DRUG LABEL | 1 | 0295-1032 | SPRAY | 25 mg | TOPICAL | OTC monograph final | 11 sections |
| CVS Maximum Strength Anti-Fungal Pen 25% | HUMAN OTC DRUG LABEL | 1 | 0295-9008 | LIQUID | 25 mg | TOPICAL | OTC monograph final | 8 sections |
| Fungi Nail Toe and Foot Anti-Fungal | HUMAN OTC DRUG LABEL | 1 | 0295-9032 | SOLUTION | 250 mg | TOPICAL | OTC monograph final | 11 sections |
| Fungicure Anti-Fungal Liquid 25% | HUMAN OTC DRUG LABEL | 1 | 0295-9810 | LIQUID | 250 mg | TOPICAL | OTC monograph final | 12 sections |
| Undecylenic Acid | HUMAN OTC DRUG LABEL | 1 | 0363-0206 | LIQUID | 25 mg | TOPICAL | OTC monograph final | 15 sections |
| Undecylenic Acid | HUMAN OTC DRUG LABEL | 1 | 0363-0206 | LIQUID | 25 mg | TOPICAL | OTC monograph final | 15 sections |
| Undecylenic Acid | HUMAN OTC DRUG LABEL | 1 | 0363-7731 | LIQUID | 0.25 g | TOPICAL | OTC monograph final | 15 sections |
| Undecylenic Acid | HUMAN OTC DRUG LABEL | 1 | 0363-7731 | LIQUID | 0.25 g | TOPICAL | OTC monograph final | 15 sections |
| Undesine | HUMAN OTC DRUG LABEL | 2 | 10578-009 | OINTMENT | 5 g | TOPICAL | OTC monograph final | 11 sections |
| SANAFITIL | HUMAN OTC DRUG LABEL | 1 | 11096-190 | OINTMENT | 100 mg | TOPICAL | OTC monograph final | 13 sections |
| Undecylenic Acid | HUMAN OTC DRUG LABEL | 1 | 11673-259 | LIQUID | 25 mg | TOPICAL | OTC monograph final | 15 sections |
| maximum strengthantifungal nail liquid | HUMAN OTC DRUG LABEL | 1 | 11673-488 | LIQUID | 7.50 g | TOPICAL | OTC monograph final | 12 sections |
| Undecylenic Acid | HUMAN OTC DRUG LABEL | 1 | 11673-634 | LIQUID | 25 mg | TOPICAL | OTC monograph final | 15 sections |
| UNDECYLENIC ACID | HUMAN OTC DRUG LABEL | 1 | 11822-0028 | LIQUID | 288 mg | TOPICAL | OTC monograph final | 8 sections |
| Undecylenic Acid | HUMAN OTC DRUG LABEL | 1 | 11822-0118 | LIQUID | 7.50 g | TOPICAL | OTC monograph final | 15 sections |
| Undecylenic Acid | HUMAN OTC DRUG LABEL | 1 | 11822-0118 | LIQUID | 7.50 g | TOPICAL | OTC monograph final | 15 sections |
| Rite Aid Fungal | HUMAN OTC DRUG LABEL | 1 | 11822-0250 | LIQUID | 288 mg | TOPICAL | OTC monograph final | 7 sections |
| RIte AidMaximum Strength Foot Care Anti-fungal Pen | HUMAN OTC DRUG LABEL | 1 | 11822-9650 | LIQUID | 250 mg | TOPICAL | OTC monograph final | 14 sections |
| Pinceladas Goyescas OriginalBrush on Fungicide | HUMAN OTC DRUG LABEL | 1 | 11856-3365 | LIQUID | 100 mg | TOPICAL | OTC monograph final | 8 sections |
| Pinceladas Goyescas OriginalFungicide | HUMAN OTC DRUG LABEL | 1 | 11856-3367 | LIQUID | 100 mg | TOPICAL | OTC monograph final | 8 sections |
| Good Neighbor Anti-Fungal | HUMAN OTC DRUG LABEL | 1 | 24385-676 | LIQUID | 250 mg | TOPICAL | OTC monograph final | 13 sections |
| Undecylenic Acid | HUMAN OTC DRUG LABEL | 1 | 36800-372 | LIQUID | 7.50 g | TOPICAL | OTC monograph final | 15 sections |
| Undecylenic Acid | HUMAN OTC DRUG LABEL | 1 | 36800-372 | LIQUID | 7.50 g | TOPICAL | OTC monograph final | 15 sections |
| TopCare AntifungalMaximum Strength | HUMAN OTC DRUG LABEL | 1 | 36800-754 | LIQUID | 25 mg | TOPICAL | OTC monograph final | 13 sections |
| TopCare AntifungalMaximum Strength | HUMAN OTC DRUG LABEL | 1 | 36800-754 | LIQUID | 25 mg | TOPICAL | OTC monograph final | 13 sections |
| Undecylenic Acid | HUMAN OTC DRUG LABEL | 1 | 41250-087 | LIQUID | 25 mg | TOPICAL | OTC monograph final | 15 sections |
| Undecylenic Acid | HUMAN OTC DRUG LABEL | 1 | 41250-087 | LIQUID | 25 mg | TOPICAL | OTC monograph final | 15 sections |
| Undecylenic Acid Liquid | HUMAN OTC DRUG LABEL | 1 | 41250-127 | LIQUID | 7.50 g | TOPICAL | OTC monograph final | 15 sections |
| Undecylenic Acid Liquid | HUMAN OTC DRUG LABEL | 1 | 41250-127 | LIQUID | 7.50 g | TOPICAL | OTC monograph final | 15 sections |
| Flexitol Anti Fungal | HUMAN OTC DRUG LABEL | 1 | 43251-3351 | LIQUID | 250 mg | TOPICAL | OTC MONOGRAPH FINAL | 14 sections |